Methods of detecting cancer based on osteopontin
US7214501B2 · kind B2 · utility
0Cited by
9References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 21, 2004 |
| Grant date | May 8, 2007 |
| Priority date | — |
| Expiry date | Jun 30, 2025 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57449
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is directed to diagnostic methods based upon the expression of the protein prostasin. In particular, it is concerned with assays performed on women to determine their risk of ovarian cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.